Introduction
============

Cancer is a hyperproliferative disorder that involves transformation, dysregulation of apoptosis, proliferation, invasion, angiogenesis and metastasis. Cancers with alarming statistics, cause more than 7 million deaths per year worldwide, more than HIV/AIDS, malaria and tuberculosis combined \[[@b1-IJCP-05-144]\]. It is estimated that the number of new cancer cases will reach 15 million every year by 2020; 70% of which will be in developing countries \[[@b2-IJCP-05-144]\]. Patients confronting a diagnosis of advanced cancer face the statistical reality that conventional chemotherapy can affect a cure for only a tiny minority of all such cases. More often than not, the reasonable impulse of these patients to investigate alternative treatment options such as herbal medicine is met with physician\'s doubt.

For a long time, natural and herbal products have been considered as precise sources of treatment used in traditional medicine to treat a variety of diseases including infections and malignant diseases \[[@b3-IJCP-05-144]\]. Several researches demonstrated the fact that extracts from a number of herbal plants exhibit anticancer activities both in vitro and in vivo \[[@b4-IJCP-05-144]-[@b10-IJCP-05-144]\]. A growing number of studies indicate that herbal medicine (looking at frequency, type and reasons for use) might have the anti-cancer effect by enhancing the immune system \[[@b11-IJCP-05-144]\], inducing cell differentiation \[[@b12-IJCP-05-144]\], inhibiting telomerase activities \[[@b13-IJCP-05-144]\] and inducing apoptosis of cancer cells \[[@b14-IJCP-05-144]\].

It is strongly believed that herbal medicines are natural and hence without significant side effects and less likely to cause dependency \[[@b15-IJCP-05-144]\]. Nevertheless, many herbs can be toxic especially in higher quantities and with frequent use. Besides, herb-synthetic drug interactions are controversial \[[@b16-IJCP-05-144]\].

The prevalence of herbs use ranges from 60 to 80% among cancer patients depending on the definition of herbal medicine used in each study, sample size, and the place where the study was conducted \[[@b17-IJCP-05-144]\]. In UK, a population-based survey indicates that about 25% of cancer patients had consulted an herbal medicine practitioner in the past, although authors suggest that this number maybe underestimated \[[@b18-IJCP-05-144]\]. A Canadian study shows that 20% of breast cancer patients used at least one herbal medicine treatment in the past\[[@b19-IJCP-05-144]\], whereas American studies more consistently report rates well above 65% \[[@b20-IJCP-05-144],[@b21-IJCP-05-144]\], such rates are considerably higher than those reported in general population \[[@b22-IJCP-05-144]\] or among other cancer diagnostic groups \[[@b23-IJCP-05-144]\].

Despite extensive use of herbal medicines in cancer care, most of the evidence is anecdotal and has not been properly studied with significant clinical trials, especially in human subjects \[[@b24-IJCP-05-144]\]. Further, interaction of chemical drug-herbs should be considered as another important factor \[[@b25-IJCP-05-144]\], because herbs cannot replace surgery or radiotherapy for early stages of cancer, even though it is believed that they do have merits of their own \[[@b26-IJCP-05-144]\].

The objective of this review is to identify the available evidence on the use of herbs and their clinical effects in cancer care. The present work intends to make a review about this subject using ISI Web of Knowledge (Thomson Reuters) database from 2000 up to 2011. In some few cases, references other than 2000 to 2011(publishing date) can be cited as introductory to more recent works. Therefore, some references are mentioned whose dates do not match the period of the study. Search keys used for the study were a combination of: Cancer; Medicinal Herbs; Immunomodulator; Preventive therapy; Safety; 2000 to 2011 (year published). About 100 works were found including proceedings and articles. Patents, abstracts, and other scientific documents whose availability was restricted were not used.

Roles of Herbal Medicines in Cancer
===================================

From 200 to 1800 AD, following the teachings of Aristotle and Galen, which was believed that cancer, was a consequence of the coagulation of "black bile" till now when prevalence of biology has contributed to a 25% reduction in mortality \[[@b27-IJCP-05-144]\], herbs play an important role in cancer symptom management, patients\' quality of life and survival.

The main objectives of herbal therapies are:

-   Primary prevention of cancer; this is important for those who have a strong family history of cancer

-   Secondary presentation; prevention of a recurrence of cancer is therefore the objective for this group

-   To enhance body\'s immune system

-   To reduce the side effects resulting from conventional therapies such as chemotherapy or radiation therapy

-   In advanced stages of cancer, when conventional therapies have failed, many patients have no choice but resort to alternative treatments

The way herbal medicine fight cancer is significantly different from conventional chemical drugs, where no DNA mutation in surviving cell occurs. Specifically, natural compounds fight cancer by strengthening the immune system preventing the spread of cancer cells through inhibition of angiogenesis or growth of new blood vessels feeding the cancer cells, detoxifying the body and preventing further toxic build-up in the body, quenching free radicals that cause mutational changes that lead to cancer formation and supporting all targeted organs, especially those affected directly by the cancer. Besides creating an unfavourable environment for cancer growth is another benefit of herbal medicines, where, the ideal environment creates a high level of oxygen and temperature including increased metabolism rate, low sugar level and a high alkalinity space in the body \[[@b28-IJCP-05-144]\].

Some of the herbs commonly used in traditional knowledge are listed in [Figure 1](#f1-IJCP-05-144){ref-type="fig"}, [2](#f2-IJCP-05-144){ref-type="fig"} and [3](#f3-IJCP-05-144){ref-type="fig"} based on active component, chemical structure and source.

The approach to treat advanced cancer using natural medicines has consisted of two main different visions. Indeed many herbal medicines are widely used as immunomodulators, although another group was known as chemopreventive (adaptogenic) plant compounds \[[@b29-IJCP-05-144]\].

Immunomodulation Versus Chemo Preventive Herbs
==============================================

An important key role for plant medicines in cancer is immunomodulation. Such natural medicines have been reported to serve as biological response modifiers by activating, increasing and restoring the reactivity of immunological effector mechanisms that are involved in resistance to tumor growth and metastasis \[[@b30-IJCP-05-144], [@b31-IJCP-05-144]\].

In fact, cancer evades immune system surveillance because of low immunogenicity of most tumors. Nonetheless, many cancer patients with advanced malignancy do have lowered levels of innate (Th1) immunity, the branch of immune system whose cells, such as Natural Killer (NK) cells, directly kill the tumor. A variety of herbal medicines and plant compounds directly stimulate this innate immune response. These same agents can be used to help protect bone marrow against the myelosuppressive effects of conventional chemotherapy. As it is described in [figure 4](#f4-IJCP-05-144){ref-type="fig"}, the two most important classes of herbs here are immunomodulating and adaptogens.

As it is described in [Figure 1](#f1-IJCP-05-144){ref-type="fig"}, in neither of the cases the herbal medicines have equivalents among pharmaceutical drugs. The mushrooms contain polysaccharides, which are not only immunostimulating of anticancer effects; they also have non-specific effects of increasing longevity and reducing stress. The adaptogenic herbs such as Panax ginseng are even more unique. Adaptogens are nonspecific, nontoxic and normalizing. This means the effect they produce varies according to the physiopathologic state. For instance, ginseng is an angiogenic in wound healing, versus cancer, and it is also antiangiogenic \[[@b32-IJCP-05-144]\]. This apparent paradox is typical of normalizing properties of adaptogens, which also have multiple anticancer effects as well as beneficial interactions with conventional chemotherapy and radiation. Some molecular targets of chemopreventive plants are illustrated in [Figure 5](#f5-IJCP-05-144){ref-type="fig"}. Most of these herbs operate on several of the mentioned targets simultaneously and often synergistically.

Immunomodulation Herbs
======================

Ganoderma lucidum, a highly ranked medicinal mushroom has potent enhancing effect on immune system and anticancer activity. Preclinical studies demonstrated its anti-tumor activity, and further studies indicated that the Polysaccharide (PS) fractions were the major active components for the anti-tumor action \[[@b33-IJCP-05-144], [@b34-IJCP-05-144]\].

Ganoderma lucidum was found to activate macrophages, T lymphocytes and NK cells and to induce the production of cytokines such as tumor necrosis factor, interleukins and interferons in in-vitro with human immune cells and in vivo in mice \[[@b35-IJCP-05-144]-[@b37-IJCP-05-144]\].

Herba taraxucum mongolicum is also shown immune stimulating effects \[[@b38-IJCP-05-144]\]. Studies indicate that its chemical constituents such as taraxasterol, taraxacin, choline, inulin and pectin remove toxic heat, swelling and nodulation.

Sophora flavescens also increases leukocytes and promotes peripheral immune response. Scutellaria baicalensis is another potent heat and toxin- clearing with anti- tumor and immune-stimulating properties in vivo and in vitro that inhibits platelet aggregation and induces apoptosis \[[@b39-IJCP-05-144]\]. Isatis tinctoria contains the compound indirubin, inhibits DNA synthesis in neoplastic cells, while simultaneously stimulating immune response \[[@b40-IJCP-05-144]\].

Also, herbs such as Panax ginseng, Poria cocos, Atractylodes macrocephala, Angelica sinensis, Ligustici wallichii, Paeonia lactiflora, Rehmannia glutinosa and Astragalus membranaceus show an increase of white blood cell counts to normal levels in cancer patients \[[@b41-IJCP-05-144]\].

Decades of pharmacological research have revealed that the polysaccharides and other compounds in Astragalus membranaceus promote cellular and humoral immune function and have vitro anti-tumor effects on cancer cell lines \[[@b42-IJCP-05-144]-[@b44-IJCP-05-144]\].

Multiple studies on patients with stomach cancer were conducted using formula Pishen Fang, which has immunostimulating properties. The formula contains: Codonopsis pilolusa, Atractylodes macrocephala, Lycium barbarum, Ligustrum lucidum, Cuscuta chinensis and Psoralea corylifolia \[[@b45-IJCP-05-144]\].

Chemopreventive Herbs
=====================

The inhibitory effect of a herbal formula comprising Ginseng and Carthamus tinctorius on breast cancer was studied by Wings et al. \[[@b46-IJCP-05-144]\]. This formula could be a useful anticancer compound against breast cancer by inhibiting proliferation in solid tumor. The compounds isolated from the pacific yew \"Taxus brevifolia\" has developed as the anticancer drug \"Taxol\". The extract from plant Scutellaria barbata has been shown to be cytotoxic to A549 human lung cancer cell lines \[[@b47-IJCP-05-144], [@b48-IJCP-05-144]\]. The synergetic effect on antiproliferative activity of chemotherapeutic agents (Doxorubicin) in combination with Thai herbal remedies (stem of Albizia procera, Diospyros mollis, Ficus hispida, smilax glabra, Gelonium multiflorum and Millingtonia hortensis) against lung cancer cells may induce DNA damage in lung cancer \[[@b49-IJCP-05-144]\]. Amooranin extract (stem) which is a triterpene acid showed a strong inhibitory effect on survival of human breast carcinoma MDA-468 and breast adenocarcinoma MCF-7 cells compared to breast epithelial MCF-10A control cells \[[@b50-IJCP-05-144]\].

Impact of herbal medicines on human breast cancer was studied by many research groups through reducing tumor burden by Resveratrol chemically modified extract \[[@b51-IJCP-05-144]\], inhibition of estrogen-dependent gene transcription by Shikonin (gromwell)\[[@b52-IJCP-05-144]\], cell cycle delay/arrest by Carcinosin, phytolacca, Conium and Thuja \[[@b53-IJCP-05-144]\]and modulating signal pathway by cacalol which is a free radical scavenging compound from Cacalia delphinifolia plant \[[@b54-IJCP-05-144]\]. Ganoderma lucidum, Astragalus mongholicus, polygonatum sibiricum, and Chinese sage herb, were observed to be effective on non-small-cell lung cancer for stage III or IV \[[@b55-IJCP-05-144]\]. Rasagenthi Lehyam (RL) is a siddha medicine, which is a poly herbal formulation for the treatment of cancer in India. It is reported that the chloroform extract of RL inhibited the growth of prostate and lung cancers \[[@b56-IJCP-05-144]\]; its governing mechanism is inhibition of pro-survival genes and up-regulating the pro-apoptotic genes.

Anti-proliferative effect of Melissa officinalis on human colon cancer cell line was well studied by Encalada et al. \[[@b57-IJCP-05-144]\]. This herb's hydroalcoholic extract also showed significant antioxidative activities by free radical scavenging. Thymoquinone (TQ) is the bioactive- constituent of the volatile oil of black seed whose anti-neoplastic and anti-inflammatory effects were studied by Gali-Muhtasib et al. \[[@b58-IJCP-05-144]\]. The combination of TQ with clinically used anti-cancer drugs led to improvements in their therapeutic index and prevented non-tumor tissues from sustaining chemotherapy-induced damage.

Vinca alkaloids which are isolated from the periwinkle plant Catharanthus roseus, also known as Vinca rosea, possess many therapeutic effects including anti-tumor activity \[[@b59-IJCP-05-144]\]. Vinca alkaloids are most commonly administrated weekly by short IV injection (1-15 min) more rarely by continuous infusion \[[@b60-IJCP-05-144]\].

Other examples of plant-derived compounds fight cancer by inhibition of protein synthesis, and cell-cycle progression blocking are currently under investigation. Extracts isolated from the leaves and stem of Amoora rohituka, alkaloid isolated from Cephalotaxus harringtonia, -lapachone which is a quinine obtained from the bark of the Lapacho tree (Tabebuia avellanedae)and Combretastatin A4 which is isolated from the stem wood of south Africa tree Combretum caffrum are the most important objectives of related researches \[[@b61-IJCP-05-144]\]. Curcumin is one of the most studied chemopreventive agents. It is a natural compound extracted from the rhizome of Curcuma longa that allows suppression, retardation or inversion of carcinogenesis \[[@b62-IJCP-05-144]-[@b85-IJCP-05-144]\].Evidence from numerous in vitro and in vivo studies have confirmed Resveratrol\'s(a polyphenol found in numerous plant species including peanuts and grapes) ability to modulate various targets and signalling pathways \[[@b86-IJCP-05-144]\].

[Table1](#t1-IJCP-05-144){ref-type="table"} demonstrates governing mechanism of some herbs including test model and cancer types \[[@b87-IJCP-05-144]\].

In addition, some vivo (human) studies are summarized in [table2](#t2-IJCP-05-144){ref-type="table"}; this table demonstrates herbal medicine effectiveness in cancer treatment \[[@b88-IJCP-05-144]\].

Anticancer Herbs\' Safety
=========================

Herb safety and herb-drug interactions are complex and controversial issues. With the increasing use of herbs, their potential abuse and toxicity effects should be considered legitimately. The safety of a drug, herb or a complex compound is always relative and contextual. Safety is determined by defining the conditions under which a substance is considered to be safe or dangerous and weighing potential benefits against possible short and long-term adverse effect.

As a matter of fact, compared to the record of approved pharmaceutical drugs with a few well-known exceptions, medicinal herbs are safer \[[@b89-IJCP-05-144]\]. Common use of herbs is rarely associated with adverse effects that are not easily reversible. These effects are seldom serious and include such transient reactions as: hot flashes, dizziness, headache, indigestion and rashes that are rapidly abated by discontinued use or dose reduction \[[@b90-IJCP-05-144]\].

The preponderance of evidence shows that when used as an adjunct to conventional medicine, herbs both enhance the desired effects and mitigate the harmful ones.

Conclusion
==========

It is estimated that more than 70% of the world\'s population cannot afford modern cancer medicines. In addition to cost, current cancer therapies are minimally effective and exhibit toxicities that are intolerable in most cases.

By this review, evidence presents that agents derived from plants used in herbal medicine can be used not only to prevent cancer but also to treat it. Because of their pharmacological safety, these agents can be used alone or as adjacent to current chemotherapeutic agents to enhance therapeutic effects and minimize chemo therapy-induced toxicity.

This research indicates that the molecular targets of chemopreventive agents are similar to those currently used to treat cancer. It is also evident that more research is required on herbal medicine to ensure and reach their full therapeutic potential.
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###### 

Laboratory Experiments of Herbs Anticancer Effects

  Type of Cancer                               Model                                                                                                         Herb                                                                                                                                                                                                                                                 Mechanism
  -------------------------------------------- ------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  HNSCC                                        SCC-25 and KB cell lines, four nude mice with s.c. inoculation of KB cells                                    Scutellaria baicalensis                                                                                                                                                                                                                              Inhibition of cell growth in vitro and in vivo, inhibition of PGE2 synthesis via suppression of COX-2 expression
  KB, KB v200 cell lines                       Asiaticoside                                                                                                  Induction of apoptosis and enhancement of the anti-tumor activity of Vincristine                                                                                                                                                                     
  Leukemia                                     U937 cell line                                                                                                Mylabris phalerlata, Scutellaria barbata,                                                                                                                                                                                                            Induction of apoptosis
  NB4, HL60 cell line                          Red orpiment                                                                                                  Induction of apoptosis                                                                                                                                                                                                                               
  AKR/J mice                                   Echinacea purpurea                                                                                            Enhancement of nonspecific immune or cellular immune systems (or of both).                                                                                                                                                                           
  CCRF-CEM,CEM/E1000, CEM/VLB(100)cell lines   Artesunate(ART), Bufalin                                                                                      ART significantly increased Daunorubicin accumulation in CEM/E1000 cells, but not in CEM/VLB (100) or CCRF-CEM parental cells, Bufalin caused a small, but significant increase in Daunorubicin accumulation in CEM/VLB (100) and CEM/E1000 cells.   
  NB4 cell line                                Arsenic trioxide                                                                                              Induction of apoptosis                                                                                                                                                                                                                               
  HL-60 cell line                              Hydrolysable tannis from Eugenia jambos L.                                                                    Induction of apoptosis                                                                                                                                                                                                                               
  HL-60,NB4,U937 and THP-1 cell line           PC-SPES                                                                                                       Inhibition of growth, induction of differentiation and apoptosis.                                                                                                                                                                                    
  Colorectal Carcinoma                         CoLo205 cell line Mice bearing colon26/ clone 20 carcinRed orpiment oma cells                                 Magnolol Coptidis rhizome and Berberine                                                                                                                                                                                                              Induction of apoptosis Reduction of IL-6 mRNA levels and protein levels in tumors and sera
  Gastric Cancer                               MGC-803 cell line AGS cell line MNK45 and KATO-III cell line                                                  Isoliquiritigenin Astragali(AR) Anemarrhena asphodeloides                                                                                                                                                                                            Induction of apoptosis Cytostatic Induction of apoptosis
  Hepatic Cancer                               Hep-G2 cell line SMMC-7221 cell line                                                                          Mognolol Isoverbascoside                                                                                                                                                                                                                             Induction of apoptosis Induction of differentiation
  Lung Cancer                                  A549 cell line Lung cancer cells                                                                              Bupleuri radix Triptolide                                                                                                                                                                                                                            Inhibition of telomerase activity and activation of apoptosis Induction of apoptosis in combination with Apo2L/ trAIL
  Breast Cancer                                95-D cell line F344 rats MCF-7 cell line MCF-7cell line MCF-7 and MCF-7/ADM cell line                         Acutiaporberine Anticancer-number-one Rosemary Tea and tea polyphenols Asiaticoside                                                                                                                                                                  Induction of apoptosis Increasement of NK cell activity increasing and inhibition of tumor metastasis. Reversing MDR Suppression of fatty acid synthase (a key enzyme in lipogenesis) Enhancement of the anti-tumor activity of Vincristine
  Ovarian Cancer                               SKOV3,CAOV3 and OVCAR-cell lines                                                                              Scutellaria barbatae                                                                                                                                                                                                                                 Induction of apoptosis
  Prostate Cancer                              LNCaP cell lines Prostate carcinoma cells Embryoid bodies and multicellular DU-145 prostate tumor spheroids   PC-SPES Equiguard Baicalein, Epicatechin, Berberine,Acteoside                                                                                                                                                                                        Activation of the JNK/c-Jun/AP-1 signal pathway resulting in growth arrest and apoptosis of prostate cancer cells Down-regulation of expression of androgen receptor and prostate- specific antigen, induction of apoptosis Down- regulation of MMp expression, inhibition of angiogenesis.
  Glioma                                       Rat C6 glioma cells Mice that injected with LZEJ-C3 cells subcuta-neously                                     Saikosaponin a,b Dang-gui-bu- xai-tang                                                                                                                                                                                                               Induction of differentiation increasing the population of activated T helper cells (CD4+CD25+)in spleen and tdLN

HNSCC: head and neck squamous cell carcinoma; PGE2: prostaglandin E2; COX-2: cyclooxygenase 2; EC: endotheliocytes; CTLs: cytotoxic T lymphocytes; TDLN: tumor-draining lymph nodes.

Anticancer-number-one: Panax ginseng, Poria cocos, Atractylodes macrocephala, Anglica sinensis, A. membranaceus, Curcuma zedoaria,Scutellaria baicalensis, Phellodenron chinense, Coptis chinensis, Glycyrrhiza uralensis, Crataegus pinnatifida, Hordeum ?ulgare, Sal?ia miltiorrhiza, Schisandra chinensis, Hedyotis diffusa, Ophiopogon japonicus, Lobelia chinesis lour, Scutellaria barbaba, Massa fermentata medicinalis; PC-SPES, Reishi mushroom, Baikal skullcap, Rabdosia, Dyer's woad, Chrysanthemum, Saw palmetto, Panax ginseng, and Licorice; Dang-gui-bu-xai-tang, Radix Angelicae sinensis and Radix Astragali membranaceus.

###### 

Human Study of Herbs Anticancer Effects

  Herb name                                                           Cancer type                                     Reported outcome
  ------------------------------------------------------------------- ----------------------------------------------- -------------------------------------------------------------------------------------
  Essiac                                                              Prostate                                        Decrease PSA levels from 87.19 to 0.12 ng/ml
  PC-SPES                                                             Prostate                                        Less than 50% decrease in PSA level
  PC-SPES                                                             Prostate                                        Decrease PSA levels from 100 to 24 ng/ml and386 to114 ng/ml
  PC-SPES                                                             Prostate                                        Decrease PSA levels from 8.8 to 0.1 ng/ml
  PC-SPES                                                             Prostate                                        Increase serum PSA levels ranging from345% to 880% after discontinuation of PC-SPES
  Chinese herbal medicine a                                           Lung                                            Complete regression
  Oriental herbal medicine and Lyophyllum decates sing                Lung                                            Partial response
  Ninjin yoei To (Traditional Chinese Medicine herbal medicine)       Lung                                            Decreased tumor marker levels CEA: 14.6 to11.3 ng/ml; CA19-9: 55 to39.2 U/ml
  Chinese herbal extract (specific herbal component not identified)   CLL                                             Complete remission
  Ganoderma lucidum                                                   Gastric large B-cell Lymphoma                   Complete regression
  Green Tea                                                           CLL                                             Partial response
  Mixture of 36 herbs                                                 Intracranial tumor(teratoid/rhabdoid tumor)     Complete response
  Hochu-ekki-to                                                       Lymphoma (Mycosis fungoides)                    Partial improvement of skin eruption
  Mistletoe                                                           Malignant melanoma                              Complete remission of liver metastasis
  Mistletoe                                                           CD 30+ cutaneous lymphoproliferative lymphoma   Complete regression
  Morinda citrifolia (noni)                                           Gastric Cancer                                  Tumor suppression
  Peruvian herbal tea                                                 Barrett\'s adenocarcinoma                       Seven year survival
  Mixture of 9 herbs                                                  Hepatocellular                                  Complete regression

PSA: Prostate Specific Antigen

a Components of Chinese herbal medicine: Herba Hedyotis diffusae, Maidony, Radix ophiopnis, pugongying Herba taraxaci, Sanqi Radix notoginseng, shancigu pseudobulbus, Cremastrae seupleiones, Xiyangshen Radix Panacis quinqufolii, Yuxingcao Herba houttuyniae, Zhebeimu Bulbus Fritillariae thunbergii, Zhibanxia Rhizoma pinelliae perparata.
